Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	963.9	1,024	231.4	401.6	-138.9	1,132
Depreciation & Amortization	958.5	951.7	926.4	937.7	898.4	1,006
Share-Based Compensation	103.8	99.8	105	76	73.8	84.3
Other Operating Activities	-524.3	-493.9	21.9	83.9	371.2	-636.2
Operating Cash Flow	1,502	1,582	1,285	1,499	1,205	1,586
Operating Cash Flow Growth	10.82%	23.11%	-14.31%	24.47%	-24.04%	-9.25%
Capital Expenditures	-709.3	-689.2	-446.2	-425.6	-370.9	-720.6
Acquisitions	-116	-134.9	-99.8	0	-227.1	-37.1
Change in Investments	30.2	33.4	89.4	1.9	53.5	48.1
Other Investing Activities	-29.4	11.8	-72.6	-79.9	-69.3	-19.7
Investing Cash Flow	-824.5	-778.9	-529.2	-503.6	-613.8	-729.3
Dividends Paid	-200	-200.9	-201.2	-200.1	-198.5	-196.7
Share Issuance / Repurchase	-416.7	-591.1	-48.3	122.5	129.8	158.2
Debt Issued / Paid	29	48.8	-1,062.3	-1,068.2	-328.2	-731.8
Other Financing Activities	-19.2	-20.3	468	-160.2	-24.9	-9.6
Financing Cash Flow	-606.9	-763.5	-843.8	-1,306	-421.8	-779.9
Exchange Rate Effect	-7.7	0.9	-14.5	-13.2	15.3	-1.5
Net Cash Flow	62.9	40.1	-102.8	-323.6	184.2	75.1
Free Cash Flow	792.6	892.4	838.5	1,074	833.6	865.2
Free Cash Flow Growth	-7.65%	6.43%	-21.90%	28.79%	-3.65%	-33.87%
Free Cash Flow Margin	10.64%	12.07%	12.08%	15.73%	13.60%	10.84%
Free Cash Flow Per Share	3.86	4.28	4.00	5.15	4.03	4.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).